In our previous articles, we reported that the Federal Circuit affirmed the district court’s decision on December 20, 2024 ...

NEW YORK CITY, NY / ACCESS Newswire / March 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...

The US shift toward steep tariffs will likely make drugs more expensive and limit access for patients, according to one of ...

Konstantina Katcheves, Senior VP of Innovative Global Business Development at Teva Pharmaceuticals brings insights from the ...

Corcept's new drug, relacorilant, shows promise with positive Phase 3 results and an FDA decision expected. Learn more about ...

Teva Pharmaceuticals filed a patent infringement lawsuit against Amneal Pharmaceuticals alleging that their generic version ...

Generic drugmakers could be significantly impacted by President Trump's decision to double the tariff on Chinese goods to 20% ...

The shoe brand has launched "For Playground Earth," a new anthem and collection created to "push people to play outside." ...

Federal Circuit says only patents claiming the active ingredient of a drug are eligible for listing | Injunction against Teva ...

The Tel Aviv Stock Exchange fell today. The Tel Aviv 35 Index fell 1.83% to 2,451.69 points; the Tel Aviv 125 Index fell 2.10% to 2,511.14 points; and the BlueTech Global Index fell 2.87% to 455.14 ...

Weeks after settling a five-year patent dispute with the U.S. | Gilead set aside approximately $200 million for a potential ...

Teva®, a division of Deckers Brands , announces the arrival of its spring-summer 2025 collection and new anthem "For Playground Earth," which was created to push people to play outside, for their own ...